UNSPSC 42203428: Angiography control valves and hemostatic valves

In this classification, this commodity indicates a product used as a control valve or hemostatic valve used in examination by X-ray of blood or lymph vessels, carried out after introduction of a radiopaque substance in a medical setting. US FDA regulates Angiography control valves and hemostatic valves under 21 CFR 870.1650 and under FDA product code OEQ. Most nations, for tariff and trade purposes, schedule these products under HS 901839.

UNSPSC 42203428, Angiography control valves and hemostatic valves (Commodity), covers specialized medical device components used in vascular imaging and intervention procedures. State and local governments procure these valves primarily through health systems, hospital networks, and emergency medical services that operate under county, city, and regional health authority oversight. The scope includes control valves that regulate fluid flow during angiographic procedures and hemostatic valves that manage bleeding control in vascular access applications. The recent solicitation activity reflects cooperative purchasing models that consolidate procurement across multiple jurisdictions and entity types, rather than individual hospital or health department RFPs for discrete medical device inventories.

The available recent opportunity shows minimal direct activity under this Commodity code. Sourcewell, a Minnesota local government unit and service cooperative, issued RFP #061626 on May 12, 2026 (due June 16, 2026) for Law Enforcement Equipment on behalf of participating entities including Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington and numerous other public entities across the United States and Canada. This solicitation does not map to angiography or hemostatic valve procurement; the law enforcement equipment classification indicates the code may have been misapplied to the opportunity record, or the opportunity represents a general cooperative purchasing framework unrelated to the Commodity's medical device scope. The lack of correlated recent opportunities under the correct scope suggests limited near-term state and local purchasing activity visible through posted RFP, RFQ, IFB, or ITB notices for angiography control valves and hemostatic valves specifically.